OREX up +25.19% percent Today $OREX High is at 4.79 and the

New Post Public Reply Private Reply Replies (0) Message Board

Nov 10, 2014 at 2:53 PM

OREX up +25.19% percent Today $OREX High is at 4.79 and the Low 4.04 with current volume of 4,685,142.

Recent News posted below.

Orexigen Therapeutics OREX other info.
http://investorshangout.com/Orexigen-Therapeu...REX-55007/

OREX Orexigen Therapeutics Recent Headline News

Arena And Vivus Investors Need To Watch Orexigen
Spencer Osborne - at Seeking Alpha - 1 hr 28 mins ago

OREX: 5.08 (+1.23), VVUS: 3.23 (-0.10), ARNA: 4.34 (+0.08)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - 1 hr 52 mins ago

UCP: 11.82 (-1.97), JRJC: 6.21 (+0.70), NAVB: 1.03 (-0.19), SANW: 3.76 (+0.68), PLPM: 1.63 (+0.26), RYN: 28.62 (-5.28), INFU: 3.02 (-0.47), LIOX: 5.49 (+0.75), DY: 27.75 (-3.12), MTZ: 25.31 (-3.32), CGIX: 6.92 (+0.92), MUX: 1.25 (-0.16), OREX: 5.08 (+1.23), URRE: 2.54 (+0.60), ACHN: 12.54 (+2.43), REN: 2.83 (-0.78), MPO: 3.33 (+0.22), AKBA: 9.28 (-1.42), TRX: 1.02 (-0.20), PLNR: 7.53 (+1.13)

Stock to Watch: Orexigen Therapeutics Up 19.5% (OREX)
Comtex SmarTrend(R) - 2 hrs 25 mins ago
Orexigen Therapeutics (NASDAQ:OREX) is one of today's best performing low-priced stocks, up 19.5% to $4.60 on 1.1x average daily volume. Orexigen Therapeutics has traded 3.6 million shares thus far today, vs. average volume of 3.3 million shares per day. The stock has outperformed the Dow (19.5% to the Dow's 0.1%) and outperformed the S&P 500 (19.5% to the S&P's 0.3%) during today's trading.
OREX: 5.08 (+1.23)

Orexigen Therapeutics' (OREX) CEO Mike Narachi on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 10:51AM CST

OREX: 5.08 (+1.23)

Orexigen ups earnings by 161% in Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 10:16AM CST

OREX: 5.08 (+1.23)

Orexigen rises as weight loss drug review proceeds
AP - Mon Nov 10, 10:02AM CST
NEW YORK (AP) — Shares of Orexigen Therapeutics Inc. jumped Monday after the company said a European Union review of its weight loss drug Contrave, which was approved in the U.S. in September, is progressing on schedule.
OREX: 5.08 (+1.23), VVUS: 3.23 (-0.10), ARNA: 4.34 (+0.08)

Orexigen Therapeutics (OREX) Stock Soars Today on Big Third Quarter Earnings Beat
at The Street - Mon Nov 10, 9:33AM CST
Orexigen Therapeutics (OREX) stock is skyrocketing this morning after the company posted higher than expected third quarter earnings.
OREX: 5.08 (+1.23)

Orexigen Beats The Street On Milestone Payments
Spencer Osborne - at Seeking Alpha - Mon Nov 10, 8:21AM CST

OREX: 5.08 (+1.23)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 8:14AM CST

PT: 1.63 (+0.11), GPRO: 76.08 (-2.98), OREX: 5.08 (+1.23), GOGO: 18.04 (+1.40), JRJC: 6.21 (+0.70), UEC: 1.87 (+0.15), ACHN: 12.54 (+2.43), ARQL: 1.16 (+0.10), CMCM: 20.50 (+0.30), IBIO: 1.24 (+0.08), DF: 16.31 (+1.89)

Orexigen Therapeutics (OREX) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Nov 10, 7:25AM CST

OREX: 5.08 (+1.23)

Orexigen Therapeutics beats by $0.22, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 6:08AM CST

OREX: 5.08 (+1.23)

Orexigen Therapeutics Reports Results for the Third Quarter Ended September 30, 2014
PR Newswire - Mon Nov 10, 6:00AM CST
Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced results for the third quarter ended September 30, 2014.
OREX: 5.08 (+1.23)

Critical Alerts For Stratasys, Orexigen Therapeutics, YY, Workday and Hong Kong Television Network Released By InvestorsObserver
PR Newswire - Fri Nov 07, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for SSYS, OREX, YY, WDAY and HKTV.
OREX: 5.08 (+1.23), YY: 81.94 (+2.44), WDAY: 95.33 (+0.77), SSYS: 104.40 (+1.33), HKTV: 11.08 (+0.21)

Orexigen Therapeutics to Present at the Credit Suisse Healthcare Conference
PR Newswire - Thu Nov 06, 3:30PM CST
Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the Credit Suisse Healthcare Conference in Phoenix. The presentation is scheduled for Tuesday, November 11th at 2:00 p.m. Mountain Time. To listen to the live webcast or a replay of the presentation, please visit the Investor Relations section of the Company's Web site at www.orexigen.com. A replay will be available for 14 days after the event.
OREX: 5.08 (+1.23)

Vivus Beats The Street On Milestone Payment For ED Drug
Spencer Osborne - at Seeking Alpha - Thu Nov 06, 7:59AM CST

OREX: 5.08 (+1.23), VVUS: 3.23 (-0.10), ARNA: 4.34 (+0.08)

Orexigen Therapeutics to Host Third Quarter 2014 Financial Results Conference Call and Webcast
PR Newswire - Tue Nov 04, 3:15PM CST
Orexigen® Therapeutics, Inc. (Nasdaq: OREX) will announce financial results for the third quarter 2014, on Monday, November 10, 2014 before markets open. The announcement will be followed by a live webcast and conference call at 8:30 a.m. Eastern time (5:30 a.m. Pacific time).
OREX: 5.07 (+1.22)

Orexigen's Contrave Has Modest Start
Spencer Osborne - at Seeking Alpha - Mon Nov 03, 12:30PM CST

OREX: 5.07 (+1.22), ARNA: 4.34 (+0.08)

Orexigen Announces Contrave® (naltrexone HCI and bupropion HCI extended release) Data Presentations at the ObesityWeek Meeting in Boston
PR Newswire - Fri Oct 31, 7:30AM CDT
Orexigen Therapeutics (NASDAQ: OREX) today announced three Contrave® (naltrexone HCI and bupropion HCI) and two disease awareness abstracts have been accepted for poster presentations at the upcoming ObesityWeek meeting. This meeting will be held November 2-7, 2014 in Boston at the Boston Convention and Exposition Center.
OREX: 5.07 (+1.22)

Orexigen Therapeutics Has Substantial Upside For Bull Investors
L&F Capital Management - at Seeking Alpha - Wed Oct 29, 7:27AM CDT

OREX: 5.07 (+1.22)

Arena Skimps on Data Disclosure From Weight-Loss Combo Study
at The Street - Wed Oct 29, 6:30AM CDT
Arena Pharmaceuticals provided very little useful information Tuesday night about the Belviq-phentermine weight-loss combination.
OREX: 5.07 (+1.22), ARNA: 4.34 (+0.08)

Orexigen Therapeutics (OREXQ) Stock Research Links

OREXQ Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Texas Institute Leads Trailblazing Arrhythmia Study

Breaking New Ground in Heart Rhythm Treatment Well, here's a twist that even the stock market folks might envy—pioneering innovation in healthcare. This time, it’s not about tech stocks or a bull market, but about real human lives. The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center in Austin has jumped to the forefront by participating in a...

OCI Energy and Arava Power Ignite SunRoper Solar Project

Bridging Houston's Energy Gap with New Solar Power There's a new player in town aiming to meet the growing electricity demand in the Houston area. On September 1, 2026, OCI Energy and Arava Power, along with their project partners, broke ground on the SunRoper Solar project in Wharton County, Texas. This isn't just any solar venture; it's a hefty 347 MWdc facility that's...

Hexaware Appoints New CEO Amid AI Growth Surge

Hexaware's Leadership Change: A Strategic Move Back in the day, leadership transitions in tech were like shooting craps—full of risk with no certainty. Today, Hexaware’s latest appointment isn’t just a roll of the dice. Appointing Vivek Jetley as CEO Designate is calculated, a strategic bid to ride the AI wave reshaping enterprise tech services. Meet the New Boss...

BC Mosaic App Store Unlocks New Tools for Researchers

Unleashing Innovation Through Specialized Apps Oh boy, it's about time someone shook things up in the research game. BC Platforms has rolled out the BC Mosaic App Store, a move that's got research types buzzing from Zurich to... well, anywhere healthcare pokes its head. These guys aren't just throwing out some generic, run-of-the-mill tools. No sir, they've created a...

Arrow's Clever DIY Push with T301 & Serena Appiah

Arrow's Halloween Play: Enter the "Light the Fright" Ever seen DIY weaponry double as a Halloween trick? Arrow Tool Group's stepping into spooky season with their "Light the Fright" Halloween Giveaway, bringing in DIY dynamo Serena Appiah to showcase their T301 Multi-Tacker Staple Gun. Now, this isn't just another run-of-the-mill promo. They're handing over an arsenal...

Subtle Cosmetic Dentistry Transformations Boost Confidence

Rethinking Cosmetic Dentistry: Small Changes, Big Impact Listen up, folks. Turns out, it's the little tweaks that make your grin shine, not an expensive overhaul. This little nugget comes straight from the mouth of Dr. Jared Giatras at Giatras Family Dentistry, Murfreesboro. The old-school perception that you need to wipe the slate clean and start fresh with a chiclet...

Top Tax Expert Holly Paz Joins alliant's Elite Team

Big Leagues in Tax: Holly Paz Joins alliant Tax is one of those fields that's not for the faint of heart. It's complex, ever-changing, and can make or break businesses. Enter Holly Paz, once at the helm of the IRS's Large Business & International Division, now bringing her vast experience to alliant. Paz is a bona fide heavyweight in tax administration, and her arrival at...

Marco's Pizza Fuels Education with $1M Donation Boost

It's not just about slinging pies for Marco's Pizza these days. They're marking a mighty milestone with a $1 million donation to Junior Achievement USA, a major player in prepping young folks to grapple with real-world financials and entrepreneurship. This hefty check not only pushes The Marco's Pizza Foundation's giving tally past the $1.5 million mark, but it also...

Battling Razor Bumps: Breaking a Persistent Cycle

Understanding Razor Bumps: More Than a Cosmetic Annoyance Crossing Great Neck this morning, I stumbled across a curious release from Laser by Aleya. Apparently, the problem with those pesky razor bumps plaguing many isn't just skin-deep. For some, especially those with coarse or curly hair, each razor stroke starts a relentless cycle of irritation that's as grinding as...

Nexio's New Campus Ignites Truck Production Ambitions

Big Moves into the Big Truck Arena Nexio Power is making significant strides in making heavy trucks powered by propane a reality. By securing a massive 77-acre campus in Anderson, Texas, the company is setting the stage for immediate production capabilities. It's not often you see a company like Nexio pulling the rug out from others so quietly but effectively. This campus...